CVS Health Corp (NYSE:CVS) has a beta value of 0.53 and has seen 11.07 million shares traded in the last trading session. The company, currently valued at $69.62B, closed the last trade at $55.34 per share which meant it gained $0.69 on the day or 1.26% during that session. The CVS stock price is -50.43% off its 52-week high price of $83.25 and 4.64% above the 52-week low of $52.77. If we look at the company’s 10-day average daily trading volume, we find that it stood at 9.89 million shares traded. The 3-month trading volume is 10.31 million shares.
The consensus among analysts is that CVS Health Corp (CVS) is Buy stock at the moment, with a recommendation rating of 1.93. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 6 out of 20 have rated it as a Hold, with 14 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 1.53.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CVS Health Corp (NYSE:CVS) trade information
Sporting 1.26% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CVS stock price touched $55.34 or saw a rise of 3.45%. Year-to-date, CVS Health Corp shares have moved -29.91%, while the 5-day performance has seen it change -1.62%. Over the past 30 days, the shares of CVS Health Corp (NYSE:CVS) have changed -15.19%. Short interest in the company has seen 20.8 million shares shorted with days to cover at 1.84.
Wall Street analysts have a consensus price target for the stock at $105.5, which means that the shares’ value could jump 47.55% from current levels. The projected low price target is $63.0 while the price target rests at a high of $127.0. In that case, then, we find that the current price level is -129.49% off the targeted high while a plunge would see the stock gain -13.84% from current levels.
CVS Health Corp (CVS) estimates and forecasts
Figures show that CVS Health Corp shares have outperformed across the wider relevant industry. The company’s shares have lost -0.72% over the past 6 months, with this year growth rate of -29.18%, compared to -35.70% for the industry. Revenue growth from the last financial year stood is estimated to be 3.30%.
17 analysts offering their estimates for the company have set an average revenue estimate of 92.75B for the current quarter. 17 have an estimated revenue figure of 96.86B for the next ending quarter.
Earnings growth for 2024 is a modest -28.33% while over the next 5 years, the company’s earnings are expected to increase by 3.73%.
CVS Dividends
CVS Health Corp is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 2.66 at a share yield of 4.81%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 2.96%.
CVS Health Corp (NYSE:CVS)’s Major holders
Insiders own 0.12% of the company shares, while shares held by institutions stand at 83.09% with a share float percentage of 83.19%. Investors are also buoyed by the number of investors in a company, with CVS Health Corp having a total of 2379.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 116.35 million shares worth more than $6.87 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.2341% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 100.15 million shares as of 2024-06-30. The firm’s total holdings are worth over $5.91 billion and represent 7.9485% of shares outstanding.
